These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 12974088)

  • 1. [Clinical features and prognostic factors of malignant ovarian teratoma].
    Jin FM; Zhu GZ; Feng YJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):427-30. PubMed ID: 12974088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9).
    Mangili G; Scarfone G; Gadducci A; Sigismondi C; Ferrandina G; Scibilia G; Viganò R; Tateo S; Villa A; Lorusso D
    Gynecol Oncol; 2010 Oct; 119(1):48-52. PubMed ID: 20599258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
    Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
    Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective analysis of 67 consecutive cases of pure ovarian immature teratoma.
    Li H; Hong W; Zhang R; Wu L; Liu L; Zhang W
    Chin Med J (Engl); 2002 Oct; 115(10):1496-500. PubMed ID: 12490095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors.
    Cicin I; Saip P; Guney N; Eralp Y; Ayan I; Kebudi R; Topuz E
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):210-4. PubMed ID: 19419810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical management of malignant ovarian germ-cell tumors: 10 years' experience of 129 patients.
    Peccatori F; Bonazzi C; Chiari S; Landoni F; Colombo N; Mangioni C
    Obstet Gynecol; 1995 Sep; 86(3):367-72. PubMed ID: 7651644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Malignant ovarian germ cell tumours: a trial of 36 cases].
    Gueye A; Narducci F; Baranzelli MC; Collinet P; Farine O; Fournier C; Vinatier D; Leblanc E
    Gynecol Obstet Fertil; 2007 May; 35(5):406-19. PubMed ID: 17350873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teratoma with malignant transformation: experiences of the cooperative GPOH protocols MAKEI 83/86/89/96.
    Biskup W; Calaminus G; Schneider DT; Leuschner I; Göbel U
    Klin Padiatr; 2006; 218(6):303-8. PubMed ID: 17080331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term follow-up of the ovarian malignant teratoma].
    Zhu GZ
    Zhonghua Fu Chan Ke Za Zhi; 1993 Apr; 28(4):220-3, 253-4. PubMed ID: 8404306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment and prognosis of stage III-IV laryngeal squamous cell carcinoma].
    Tian WD; Zeng ZY; Chen FJ; Wu GH; Guo ZM; Zhang Q
    Ai Zheng; 2006 Jan; 25(1):80-4. PubMed ID: 16405756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ovarian growing teratoma syndrome clinical study of 22 cases].
    Cheng NH; Huang HF; Lian LJ; Wu Y
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jun; 44(6):426-30. PubMed ID: 19953942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients.
    Li J; Yang W; Wu X
    Gynecol Oncol; 2007 Jun; 105(3):769-75. PubMed ID: 17459461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of adjuvant paclitaxel and carboplatin for advanced stage epithelial ovarian cancer: a population-based cohort study of all patients in western Sweden with long-term follow-up.
    Akeson M; Zetterqvist BM; Dahllöf K; Brännström M; Horvath G
    Acta Obstet Gynecol Scand; 2008; 87(12):1343-52. PubMed ID: 18951208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic analysis of 151 patients with maxillary sinus malignant neoplasms].
    Guo GF; Yang AK; Xie RH; Chen ZH; Wu QL; Ou SM; Liu WW; Xia LP; Chen MY; Zhang JX; Wu JH
    Ai Zheng; 2004 Nov; 23(11 Suppl):1546-50. PubMed ID: 15566677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases.
    Low JJ; Perrin LC; Crandon AJ; Hacker NF
    Cancer; 2000 Jul; 89(2):391-8. PubMed ID: 10918171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pure Immature Teratoma of the Ovary in Adults: Thirty-Year Experience of a Single Tertiary Care Center.
    Alwazzan AB; Popowich S; Dean E; Robinson C; Lotocki R; Altman AD
    Int J Gynecol Cancer; 2015 Nov; 25(9):1616-22. PubMed ID: 26332392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The characteristics diagnosis and treatment of hepatic metastasis of simple immature ovarian teratoma].
    Fan Q; Huang H; Lian L
    Zhonghua Fu Chan Ke Za Zhi; 2000 Oct; 35(10):613-6. PubMed ID: 11372414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant ovarian germ cell tumors: clinico-pathological presentation and survival outcomes.
    Tangjitgamol S; Hanprasertpong J; Manusirivithaya S; Wootipoom V; Thavaramara T; Buhachat R
    Acta Obstet Gynecol Scand; 2010; 89(2):182-9. PubMed ID: 19961281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.